Avro, a sciences startup in Y Combinator’s batch, is on a method to deliver to populations unable to swallow or chew — it will administer them through the skin. Starting with allergy , the startup is developing skin that drugs commonly used in seasonal allergies for children. The patches can deliver a variety of drugs. Read More